Halozyme Therapeutics 1 article

Halozyme Therapeutics occupies the enabling-technology layer of biotechnology as a drug-delivery technology company with biopharmaceutical royalty economics, particularly through drug delivery technology. Its platform or service base spans high-volume subcutaneous drug delivery and biologic co-formulation technology, with antibody delivery partnerships showing where the company participates in research, manufacturing or evidence generation. In GenoMethods, specific tools, assays, reagents and services are mapped separately; the organizational capability set of Halozyme Therapeutics also includes extracellular matrix permeability modulation.